← Leaderboards
Eellan Sivanesan
Johns Hopkins University
$1,412,130
Attributed
$1,412,130
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $282.4K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,412,130 · 1
By mechanism
K08$1,412,130 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Yun Guan$12,204,762
- Michael T Smith$23,906,643
- Sridevi V. Sarma$10,508,138
- Barbara Stauch Slusher$18,499,514
- Noah John Cowan$5,588,841
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareClinical TrialsAmyloid Beta-ProteinAnesthesiologyAmerican Society Of Clinical OncologyAttenuationBiologyBlood VesselsCalciumCancer BiologyAttenuatedCancer PainCancer SurvivorCancer TherapyCareerCell ProliferationC FiberChemotherapyChemotherapy-Induced Peripheral NeuropathyChronic Painful ConditionChronic Pain PatientClinically RelevantCancer CellControl Theory
Grant awards (5)
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy$282,426
K08 · FY2025 · CA · contact PI
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy$282,426
K08 · FY2024 · CA · contact PI
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy$282,426
K08 · FY2023 · CA · contact PI
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy$282,426
K08 · FY2022 · CA · contact PI
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy$282,426
K08 · FY2021 · CA · contact PI